Tag: Cell Therapy
Cipla partners ImmunoACT to launch talicabtagene autoleucel, an anti-CD19 CAR-T cell...
Under this partnership, Cipla will commercialize talicabtagene autoleucel, India’s first indigenously developed CAR-T cell therapy, in the Republic of South Africa, Algeria, and Morocco
Ramaiah Memorial Hospital & Ramaiah Medical College to host global WBMT...
The symposium marks a significant milestone for Indian healthcare, focusing on the next frontier of treatment
Miltenyi Biotec India and BIRAC sign LoI to advance India’s cell...
The partnership will focus on building local scientific capabilities, CAR-T clinical trials, addressing unmet medical needs and enhancing access through PoC manufacturing centers to strengthen India’s CGT capabilities
DKMS opens applications for 2025 John Hansen Research Grant, offering nearly...
Up to four projects in stem cell transplantation and cell therapy to receive €240,000 each; applications open until November 20, 2024
SMART develops efficient CAR T-cell production using microfluidic bioreactor
Breakthrough technique promises cost-effective, scalable cancer therapy, reducing production time and expenses
Revvity signs new license agreement with AstraZeneca for Next-Gen Base Editing...
Non-exclusive agreement provides AstraZeneca access to proprietary gene editing technology to help advance its work in cell therapy
Juniper Biologics acquires cell-mediated gene therapy for treatment of knee osteoarthritis
The US$ 600 million acquisition will see Juniper Biologics offer the world's first cell-mediated gene therapy to an estimated 300 million patients in Asia Pacific, Middle East and Africa
Endiya Partners invest in cell therapy company, Eyestem
The company is poised to become one of the first companies in the world to develop a treatment for Dry AMD (Age-related Macular Degeneration), the largest cause of incurable blindness that affects nearly 170 million people worldwide...........................
A treatment for ‘Retinitis Pigmentosa’ could be in the offing
In their new study, researchers, who hailed from the Department of Biotechnology’s New Delhi-based National Institute of Immunology (DBT-NII) and Dr. Rajendra Prasad Centre for Ophthalmic Sciences at All India Institute of Medical Sciences, assessed the potential of monocytes..............
Regenerative medicine can displace current treatments in CVMD space, says GlobalData
As per the GlobalData, key opinion leaders interviewed by it are eager to have these novel treatments at their disposal, especially for patients with advanced heart failure...………..